Delaware Eye Care Center Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 Ne Front St, Milford, DE 19963 Phone: 302-653-9200 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1197 Airport Rd Ste 1, Milford, DE 19963 Phone: 302-422-2020 |
Dr. Karen L Slate, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 101 Wellness Way, Milford, DE 19963 Phone: 302-424-5420 Fax: 302-424-5426 |
Dr. Lance E Underwood, OD Optometrist Medicare: Medicare Enrolled Practice Location: 915 N Dupont Blvd Ste 1, Milford, DE 19963 Phone: 302-651-4413 Fax: 302-651-4445 |
Dr. Medhat R Iskander, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1197 Airport Rd Ste 1, Milford, DE 19963 Phone: 302-734-5861 Fax: 302-734-1921 |
Whitfield Eugene Warmouth, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 Ne Front St, Milford, DE 19963 Phone: 302-422-5155 Fax: 302-422-5118 |
I Joel Halpern, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 703 N Dupont Blvd, Milford, DE 19963 Phone: 302-499-4449 Fax: 302-459-3777 |
Halpern Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1197 Airport Rd, Milford, DE 19963 Phone: 302-422-2020 Fax: 302-422-4507 |
News Archive
Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.
Psychological interventions intended to prevent the development of post-traumatic stress disorder (PTSD) in the early stages after a traumatic experience have not been shown to be effective, Cochrane Researchers have concluded. This systematic review focused on multiple-session treatments for everyone involved, irrespective of the presence of symptoms. Two previous reviews found single session interventions to be ineffective.
Coronary artery disease is the most common type of heart disease, according to the Centers for Disease Control and Prevention. About 18.2 million adults in the United States have coronary artery disease.
A study led by UT Southwestern Medical Center researchers has uncovered key molecular pathways behind the disruption of the gut's delicate balance of bacteria during episodes of inflammatory disease.
REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.
› Verified 6 days ago